D
Greenwich LifeSciences, Inc. GLSI
$11.67 -$0.26-2.18% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 132.03% 117.99% 87.79% 4.70% -17.77%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 72.16% 74.12% 71.66% 14.67% 13.71%
Operating Income -72.16% -74.12% -71.66% -14.67% -13.71%
Income Before Tax -76.08% -79.37% -77.57% -17.45% -15.30%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -76.08% -79.37% -77.57% -17.45% -15.30%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -76.08% -79.37% -77.57% -17.45% -15.30%
EBIT -72.16% -74.12% -71.66% -14.67% -13.71%
EBITDA -72.19% -74.15% -71.68% -14.68% -13.72%
EPS Basic -71.60% -75.80% -74.67% -15.49% -13.96%
Normalized Basic EPS -71.65% -75.81% -74.68% -15.47% -13.91%
EPS Diluted -71.60% -75.80% -74.67% -15.49% -13.96%
Normalized Diluted EPS -71.65% -75.81% -74.68% -15.47% -13.91%
Average Basic Shares Outstanding 2.66% 1.88% 1.29% 1.49% 0.96%
Average Diluted Shares Outstanding 2.66% 1.88% 1.29% 1.49% 0.96%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --